AUM $120.0MER 0.79%NAV $43.44Holdings —Inception Oct 2024
Price Chart
Key Statistics
Previous Close
$43.94Day Range
$42.16$43.72
52-Week Range
$29.44$48.44
Avg Volume
2.8KDividend Yield
—Expense Ratio
0.79%AUM
$120.0MShares Outstanding
2.7METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Country Allocation
| Country | Weight % |
|---|---|
| United States | 93.37% |
| United Kingdom | 6.63% |
Fund Information
- Issuer
- Emerald
- Inception Date
- Oct 21, 2024
- Exchange
- NASDAQ
- Description
- LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to have growth potential that meet the criteria of technological advancement, market disruption, or artificial intelligence. The broad life science field includes biotechnology, pharmaceutical, medical diagnostics and devices, healthcare services and technologies, and synthetic biology. Stock selection employs an extensive 10-step research process that includes reviews of publicly available and third-party information, peer reviews, financial and valuation models, internal research, surveys, as well as interviews and contact with management, industry and medical professionals, supply chain, and collaboration within the investment team. The fund may invest up to 20% in foreign companies listed on a US exchange.
The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund issued by Emerald that launched on Oct 21, 2024. It currently manages $120.0M in assets under management. The fund charges an expense ratio of 0.79%.
Top 10 holdings represent 52.7% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | CORT | Corcept Therapeutics Inc | 7.29% | 75,436 | $8.8M |
| 2 | LIVN | LivaNova PLC | 6.63% | 105,381 | $8.0M |
| 3 | TVTX | Travere Therapeutics Inc | 6.58% | 140,245 | $7.9M |
| 4 | COGT | Cogent Biosciences Inc | 6.09% | 235,467 | $7.4M |
| 5 | SYRE | Spyre Therapeutics Inc | 5.49% | 71,476 | $6.6M |
| 6 | BLLN | Billiontoone Inc | 4.75% | 54,115 | $5.7M |
| 7 | GH | Guardant Health Inc | 4.47% | 30,504 | $5.4M |
| 8 | REPL | Replimune Group Inc | 4.43% | 408,338 | $5.3M |
| 9 | MANE | VeraDermics Inc | 3.57% | 37,030 | $4.3M |
| 10 | MIRM | Mirum Pharmaceuticals Inc | 3.41% | 49,574 | $4.1M |
| 11 | CYTK | Cytokinetics Inc | 3.38% | 62,691 | $4.1M |
| 12 | AXSM | Axsome Therapeutics Inc | 3.37% | 22,951 | $4.1M |
| 13 | TMDX | TransMedics Group Inc | 3.27% | 50,164 | $3.9M |
| 14 | TWST | Twist Bioscience Corp | 2.92% | 18,580 | $3.5M |
| 15 | ICUI | ICU Medical Inc | 2.70% | 20,343 | $3.3M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -4.05% | |
| 1W | -5.00% | |
| 1M | -9.12% | |
| 3M | -11.11% | |
| 6M | +20.11% | |
| YTD | +16.95% | |
| 1Y | +40.73% | |
| 3Y | +68.45% | |
| 5Y | +68.45% |
Moving Averages
20-Day MA
$44.75
Below 20-Day MA50-Day MA
$45.95
Below 50-Day MA200-Day MA
$40.22
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$48.44
Current Price
$42.16
52-Week Low
$29.44
$29.44$48.44
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
No category data available for comparison.
Compare with Another ETF
Search for an ETF to compare with LFSC:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.